Preparation method of matrix material for culturing woven bone organ, matrix material and application

By introducing antioxidant enzymes and active calcium phosphate minerals into GelMa hydrogels, combining DNA molecules to form a dual network hydrogel, the microenvironment regulation and cell differentiation problems of bone defect repair in bone tissue engineering are solved, and bone braided is achieved Effective culture and bone repair of organoids.

CN119055836APending Publication Date: 2024-12-03SHANGHAI UNIV +1
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411182436.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

In the repair of bone defects, existing bone tissue engineering has difficulty in local microenvironment regulation, unclear biological mechanism, difficulty in time-based control of biological active factors and natural bone microstructure differences, which affects the clinical treatment effect, and it is difficult to precisely regulate bone organoid construction. Osteoblasts and mineralization.

Method used

The functional transformation of GelMa was performed by enzyme grafting strategy, and the antioxidant enzyme was grafted into the GelMa hydrogel network through the crosslinker AC-PEG-NHS, and active calcium phosphate minerals and DNA molecules were introduced to regulate the mechanical properties of the matrix material. and functionally active, forming a dual network hydrogel to promote cell-induced differentiation of braided bone organoids.

Benefits of technology

It has achieved effective cultivation of braided bone organoids, with suitable physical and chemical properties, good biocompatibility and functional activities, which can effectively regulate the induction and differentiation of bone marrow mesenchymal stem cells, and promote the self-organization formation and bone of braided bone organoids. repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055836A_ABST
    Figure CN119055836A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a matrix material for culturing a braided bone organoid, the matrix material and application, and belongs to the technical field of organoid preparation. Specifically, the matrix material hydrogel for weaving the bone organ based on bone matrix component bionic design is applied to culture of the bone organ. The matrix material is based on GelMa hydrogel, catalase is loaded through an enzyme grafting method, DNA and energy active calcium phosphate are introduced, and double-network functional hydrogel is formed and used for culture of woven bone organs. The matrix material prepared by regulation and control has good mechanical properties, is beneficial to proliferation and three-dimensional culture of cells, has good osteogenesis and mineralization advantages in culture of woven bone organs, has anti-inflammatory and vascularization functional characteristics, is suitable for bone defect repair, and provides an experimental basis for construction of bone organs and bone regeneration and repair.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of organoid preparation, and specifically relates to a preparation method, a matrix material and an application of a matrix material for culturing woven bone organoids. Background Art

[0002] Bones have a certain self-repair ability. Under normal circumstances, fractures can be regenerated through the bone healing process. The bone healing process is divided into four stages: hematoma organization stage, callus formation stage, bony healing stage, and bone remodeling stage. Among them, woven bone is the main bone tissue form in the bony healing period, which is obtained by the mineralization of fibrous callus. In the final bone remodeling stage, woven bone is slowly replaced by lamellar bone to achieve bone repair. However, when the bone defect exceeds a certain range, it is often difficult to self-repair. Under pathological conditions, the cell and matrix components in the bone microenvironment change, which hinders bone regeneration. In addition, the progress of research related to bone regeneration and repair is limited by factors such as unclear bone regeneration regulation mechanisms, unclear cell communication networks, and lack of in vitro research models.

[0003] At present, bone tissue engineering is the most commonly used strategy for repairing bone defects in clinical practice. By carrying cells and growth factors on scaffold materials, implants are endowed with certain biocompatibility and functional activity, making it the best substitute for autologous bone transplantation. However, in recent years, bone tissue engineering research has gradually reached a bottleneck: lack of regulation of the local microenvironment, unclear biological mechanisms of repair, difficulty in time-controlled release of bioactive factors, large differences in microstructural components from natural bones, etc., which seriously affect its clinical treatment effect. Therefore, there is an urgent need to develop new research tools and regeneration technologies.

[0004] Based on the difficulty of bone repair, bone organoids came into being. Bone organoids are a type of 3D self-renewing and self-organizing micro-bone tissue with bionic spatial structural characteristics. They are constructed based on bioactive materials and driven by bone stem cells. They can form vital living tissue in vitro and simulate the physiological and pathological characteristics of bones. They are used for the study of bone development and regulatory mechanisms, bone regeneration and repair, drug screening, and material evaluation. At present, the construction of bone organoids is still in its infancy. Compared with soft tissue organoids, bone organoids require precise regulation of osteoblast bone matrix secretion and mineralization, and their correct arrangement at the spatial level, so there are many difficulties.

[0005] The key to the design of bone organoids is to achieve precise cell differentiation regulation on suitable matrix scaffold materials. Woven bone is the bone structure of the embryonic period and children under 5 years old. It is also the bone tissue formed at the beginning of the fracture repair period. It has important reference significance in the study of bone regeneration and repair. The main characteristics of woven bone are immature bone cells, large size, large number, thick collagen fibers, disordered arrangement, and woven shape. In addition, early woven bone contains high concentrations of mesenchymal stem cells and cytokines, which can guide cells to differentiate into osteoblasts and build a bone tissue cell communication network. Therefore, the structure and composition of the bionic woven bone matrix are used to construct a matrix material for culturing woven bone organoids, and to achieve directional induction and regulation of stem cells, which is conducive to promoting research related to bone regeneration and repair. Summary of the invention

[0006] The present invention provides a method for preparing a matrix material for culturing woven bone organoids, a matrix material and an application thereof, and proposes an enzyme grafting strategy to functionally transform GelMa, and grafts antioxidant enzymes into the GelMa hydrogel network through a crosslinking agent AC-PEG-NHS, thereby giving the hydrogel unique anti-inflammatory and antioxidant properties, so as to protect the woven bone organoids from damage by the inflammatory microenvironment as much as possible. By introducing active calcium phosphate minerals and DNA molecules into the hydrogel network to regulate the mechanical properties and functional activity of the matrix material, it is beneficial to induce differentiation of cells in the woven bone organoids. The prepared matrix material has suitable physicochemical properties, good biocompatibility, and excellent functional activity, and can be used for the culture of woven bone organoids.

[0007] In one aspect, the present application provides a method for preparing a matrix material for culturing woven bone organoids, comprising the following steps:

[0008] S1: provides antioxidant enzymes; AC-PEG-NHS chemical crosslinker, LAP photoinitiator;

[0009] S2: Mix the antioxidant enzyme solution and 0.5% LAP aqueous solution, add AC-PEG-NHS, vortex and shake for 5 minutes in the dark, filter and sterilize with a 0.22 μm filter membrane, and incubate at 4°C in the dark for 18 to 24 hours;

[0010] S3: Prepare GelMa solution, soak GelMa in PBS, heat and dissolve at 60-70°C for 20-120 minutes, filter and sterilize with a 0.22 μm filter membrane to prepare GelMa solution, and store at a temperature below -20°C;

[0011] S4: Synthesize energy-active calcium phosphate or provide other calcium phosphate or mineral materials;

[0012] S5: Prepare DNA solution, add DEPC water to Y-1, Y-2, Y-3, L-1, and L-2, vortex to dissolve, mix Y-1, Y-2, and Y-3 to prepare a Y-DNA mixed solution, mix L-1 and L-2 to prepare an L-DNA mixed solution, and store at a temperature below -20°C;

[0013] S6: the solution obtained in S2 is mixed with the solution obtained in S3 at a mass ratio of 1:1, and the energy-active calcium phosphate obtained in S4, the Y-DNA solution obtained in S5 and the L-DNA solution are added, and the mixture is vortexed thoroughly to prepare a hydrogel precursor solution, which is stored at a temperature below -20°C away from light;

[0014] S7: The hydrogel precursor solution obtained in S6 is irradiated under a 405 nm light source for 10-60 seconds to gelate it for two-dimensional cell culture. For organoid culture, the cells are resuspended with the hydrogel precursor solution obtained in S6 and then gelated.

[0015] Preferably, the concentration of the antioxidant enzyme solution in S2 is 10-200 mg / mL; the molar ratio of AC-PEG-NHS to antioxidant enzyme in the solution obtained in S2 is 2:1 to 6:1, and AC-PEG-NHS can also be replaced by a cross-linking agent such as EDC and NHS.

[0016] Preferably, the amino substitution degree of the GelMa obtained in S3 is 10% to 90%, and the concentration of the solution is 1% to 20%.

[0017] Preferably, the energy-active calcium phosphate in S4 is provided by breaking high-energy phosphate bonds of high-energy phosphate molecules under enzyme catalysis to provide phosphate ions and energy, and the phosphate ions combine with calcium ions in the solution to generate energy-active calcium phosphate, and the specific steps are:

[0018] S41: Provide adenosine triphosphate, creatine phosphate or other high-energy phosphate molecules, calcium chloride or other water-soluble calcium salts and alkaline phosphatase.

[0019] S42: Add 1.5 mL of an aqueous solution containing 10 to 650 mg of high-energy phosphoric acid molecules and 1 mL of an aqueous solution containing 5 to 100 mg of a water-soluble calcium salt to 60 mL of water.

[0020] S43: The pH of the solution obtained in S42 is adjusted to 8.0-8.5 with 0.2 M NaOH solution.

[0021] S44: Add 0.1 mL of an aqueous solution containing 1 to 20 mg of alkaline phosphatase to the solution obtained in S43 and react for 0.5 to 6 hours under magnetic stirring at room temperature. During the reaction, the pH is maintained at 8.0 to 8.5.

[0022] S45: centrifuging the reaction solution obtained in S44 to obtain energy-active calcium phosphate, washing with ultrapure water and anhydrous ethanol at least once each, and storing in anhydrous ethanol at -20°C;

[0023] Preferably, the molar concentration of the Y-DNA and L-DNA solutions in S5 is 5 to 200 μM.

[0024] Preferably, the mass concentration of the energy-active calcium phosphate in the hydrogel precursor solution obtained in S6 is 1-200 mg / mL; the molar concentration of Y-DNA and L-DNA in the hydrogel precursor solution obtained in S6 is 10-2000 nM.

[0025] Preferably, the two-dimensional cell culture method described in S7 is: melt the hydrogel precursor solution in a 37°C water bath away from light, inject it into the well plate in a warm state, and irradiate it under a 405nm light source for 10-60s to gel it. Add the culture medium to the well to cover the gel, place it in a 37°C incubator for 5 minutes, and then switch to a cell suspension for culture.

[0026] On the other hand, the present application also provides a matrix material for culturing woven bone organoids, which is prepared by any of the above-mentioned matrix material preparation methods for culturing woven bone organoids.

[0027] On the other hand, the present application also provides a use of the above-mentioned preparation method or the above-mentioned matrix material for culturing woven bone organoids in the preparation of bone repair and bone regeneration materials.

[0028] Preferably, according to the application described above, the application is to use the double network hydrogel material as an organoid culture matrix to form woven bone organoids after inducing differentiation.

[0029] Beneficial effects:

[0030] 1. The present invention adopts a bionic strategy to prepare a suitable hydrogel matrix material for woven bone organoid culture, which has the main characteristics of having suitable mechanical properties, good biocompatibility, and exhibiting certain osteogenic, tubular, and anti-inflammatory activities. When used for the culture of woven bone organoids, it can effectively regulate the induced differentiation of bone marrow mesenchymal stem cells, so that they self-organize to form woven bone organoids with spatial characteristic structures. On the one hand, the energy-active calcium phosphate in the matrix material can achieve rapid and controllable release of calcium and phosphorus ions, promoting cell proliferation and osteogenic differentiation in woven bone organoids;

[0031] 2. In the present invention, DNA molecules form a network structure through physical cross-linking, and the DNA network serves as an in vitro mineralization template to promote the formation of hydroxyapatite in the matrix of woven bone organoids. In the application of bone repair, the antioxidant enzymes in the matrix material of the constructed woven bone organoids can protect the woven bone organoids from damage by the inflammatory microenvironment as much as possible and promote angiogenesis. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0033] Figure 1 This is a photo of the hydrogel in the present invention;

[0034] Figure 2 is a scanning electron microscope photograph of the hydrogel of the present invention;

[0035] Figure 3 is the rheological curve of the hydrogel in the present invention;

[0036] Figure 4 CCK-8 result diagram of the effect of the hydrogel of the present invention on the proliferation of bone marrow mesenchymal stem cells in two-dimensional culture;

[0037] Figure 5 This is an alkaline phosphatase staining diagram of the effect of the hydrogel in the present invention on the osteogenic differentiation of bone marrow mesenchymal stem cells in two-dimensional co-culture;

[0038] Figure 6 This is an Alizarin red staining image showing the effect of the hydrogel of the present invention on the formation of calcium nodules of bone marrow mesenchymal stem cells in two-dimensional co-culture;

[0039] Figure 7 Fluorescence staining of the effect of the hydrogel of the present invention on the production of reactive oxygen species in bone marrow mesenchymal stem cells after LPS stimulation in two-dimensional co-culture;

[0040] Figure 8 This is a fluorescence staining result diagram of the hydrogel in the present invention affecting angiogenesis of human umbilical vein endothelial cells;

[0041] Fig. 9 This is a macroscopic physical picture of the hydrogel used in the present invention for the construction of woven bone organoids and the cell morphology under bright field;

[0042] Fig.10 The hydrogel of the present invention is applied to the three-dimensional live-dead staining and three-dimensional skeleton staining of cells in woven bone organoids;

[0043] Fig.11 It is a Micro-CT three-dimensional reconstruction image after the hydrogel in the present invention is used to construct a woven bone organoid and a scanning image of the sagittal and horizontal planes of the woven bone organoid;

[0044] Fig.12 The present invention is a flow chart of the steps of the method for preparing the hydrogel. DETAILED DESCRIPTION

[0045] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0046] In conjunction with the accompanying drawings, some embodiments of the present application are described in detail below. In the absence of conflict, the following embodiments and features in the embodiments can be combined with each other.

[0047] Embodiment 1:

[0048] This embodiment provides a method for preparing a matrix material for culturing woven organoids, referring to Figures 1 to 8 Based on GelMa, catalase (CAT), energy-active calcium phosphate (EACP), and DNA molecules were introduced to prepare double network functionalized hydrogel (CGDE), including the following steps:

[0049] S1: Provide CAT; AC-PEG-NHS chemical crosslinker, LAP photoinitiator;

[0050] S2: Mix 10-200 mg / mL CAT solution and 0.5% LAP aqueous solution, add crosslinker AC-PEG-NHS at a molar ratio of 2:1 to 6:1 with CAT, vortex and shake for 5 minutes in a dark place, filter and sterilize with a 0.22 μm filter membrane, and incubate at 4°C in a dark place for 18 to 24 hours;

[0051] S3: Prepare GelMa solution, soak GelMa in PBS, heat and dissolve at 60-70°C for 20-120 minutes, filter and sterilize with a 0.22 μm filter membrane to prepare a 5-20% GelMa solution, and store at a temperature below -20°C;

[0052] S4: Synthetic energy active calcium phosphate;

[0053] S5: Prepare DNA solution, add DEPC water to Y-1, Y-2, Y-3, L-1, and L-2, vortex to dissolve, mix Y-1, Y-2, and Y-3 to prepare a Y-DNA mixed solution with a concentration of 50 to 200 μM, mix L-1 and L-2 to prepare a L-DNA mixed solution with a concentration of 50 to 200 μM, and store at a temperature below -20°C;

[0054] S6: The solution obtained in S2 is mixed with the solution obtained in S3 at a mass ratio of 1:1, 10-200 mg of the energy-active calcium phosphate obtained in S4, 1-40 μL of the Y-DNA solution obtained in S5 and 1.5-60 μL of the L-DNA solution obtained in S5 are added to 1 ml of the mixed solution, and the mixture is thoroughly vortexed to obtain a hydrogel precursor solution, which is stored at a temperature below -20°C away from light;

[0055] S7: The hydrogel precursor solution obtained in S6 is irradiated under a 405 nm light source for 10-60 seconds to gelate it for two-dimensional cell culture. For organoid culture, the cells are resuspended with the hydrogel precursor solution obtained in S6 and then gelated.

[0056] In this embodiment, the specific synthesis steps of the energy-active calcium phosphate in step S4 are:

[0057] S41: Provide adenosine triphosphate or other high-energy phosphate molecules, calcium chloride or other water-soluble calcium salts and alkaline phosphatase.

[0058] S42: Add 1.5 mL of an aqueous solution containing 10 to 650 mg of high-energy phosphoric acid molecules and 1 mL of an aqueous solution containing 5 to 100 mg of a water-soluble calcium salt to 60 mL of water.

[0059] S43: The pH of the solution obtained in S42 is adjusted to 8.0-8.5 with 0.2 M NaOH solution.

[0060] S44: Add 0.1 mL of an aqueous solution containing 1 to 20 mg of alkaline phosphatase to the solution obtained in S43 and react for 2.5 to 6 hours under magnetic stirring at room temperature. During the reaction, the pH is maintained at 8.0 to 8.5.

[0061] S45: centrifuging the reaction solution obtained in S44 to obtain energy-active calcium phosphate, washing with ultrapure water and anhydrous ethanol at least once each, and storing in anhydrous ethanol at a temperature below -20°C;

[0062] Specifically, refer to Figure 1 , a physical picture of the hydrogel's gelation is given. It can be seen that the hydrogel has good gelation properties and appears light milky white due to the loading of EACP.

[0063] Figure 2The scanning electron microscopy image of the hydrogel is given, showing that CAT-GelMa / DNA / EACP has good porosity and appropriate pore size, which is conducive to the 3D culture of cells.

[0064] Figure 3 The rheological curve of the hydrogel is given, indicating that CAT-GelMa / DNA / EACP has good mechanical properties, the storage modulus is greater than the loss modulus, which is consistent with the characteristics of elastic solids.

[0065] Figure 4 The CCK-8 results of the hydrogel's effect on cell proliferation in 2D culture are given. Similar to the control group, there was no significant difference in the proliferation of BMSCs in the CAT-GelMa / DNA / EACP group, indicating that the hydrogel has good biocompatibility.

[0066] Figure 5 The alkaline phosphatase staining diagram of the hydrogel promoting osteogenic differentiation of bone marrow mesenchymal stem cells is given. Compared with the control group, the alkaline phosphatase content of cells in the CAT-GelMa / DNA / EACP group is higher, indicating that the hydrogel has a promoting effect on osteogenic differentiation.

[0067] Figure 6 The alizarin red staining image of the hydrogel's effect on promoting the formation of calcium nodules in bone marrow mesenchymal stem cells is given. Compared with the control group, the content of calcium nodules generated by cells in the CAT-GelMa / DNA / EACP group is higher, indicating that the hydrogel can effectively promote the osteogenic mineralization of cells.

[0068] Figure 7 Fluorescence staining of the hydrogel to reduce the production of intracellular reactive oxygen species in bone marrow mesenchymal stem cells after LPS stimulation was given. Compared with the control group, the content of reactive oxygen species in the CAT-GelMa / DNA / EACP group was lower, indicating that the hydrogel can effectively reduce the production of intracellular reactive oxygen species under the stimulation of an inflammatory environment.

[0069] Figure 8 The fluorescence staining results of the hydrogel promoting angiogenesis of human umbilical vein endothelial cells are shown. Compared with the control group, the number of tubes and branches in the vascular network in the CAT-GelMa / DNA / EACP group is greater, indicating that the hydrogel can effectively promote angiogenesis.

[0070] Embodiment 2:

[0071] This embodiment provides a method for preparing a matrix material for culturing woven organoids. Based on GelMa, catalase (CAT) and energy-active calcium phosphate (EACP) are introduced to prepare a functionalized hydrogel (CGE). Compared with Example 1, the difference of this embodiment is:

[0072] Among S1-S5, the preparation of the DNA solution described in S5 is omitted.

[0073] S1: Provide CAT; AC-PEG-NHS chemical crosslinker, LAP photoinitiator;

[0074] S2: Mix 10-200 mg / mL CAT solution and 0.5% LAP aqueous solution, add crosslinker AC-PEG-NHS at a molar ratio of 2:1 to 6:1 with CAT, vortex and shake for 5 minutes in a dark place, filter and sterilize with a 0.22 μm filter membrane, and incubate at 4°C in a dark place for 18 to 24 hours;

[0075] S3: Prepare GelMa solution, soak GelMa in PBS, heat and dissolve at 60-70°C for 20-120 minutes, filter and sterilize with a 0.22 μm filter membrane to prepare a 5-20% GelMa solution, and store at a temperature below -20°C;

[0076] S4: Synthetic energy active calcium phosphate;

[0077] S5: Step omitted, none;

[0078] S6: The solution obtained in S2 is mixed with the solution obtained in S3 in a mass ratio of 1:1, 10-200 mg of the energy-active calcium phosphate obtained in S4 is added to 1 ml of the mixed solution, and the mixture is thoroughly vortexed to obtain a hydrogel precursor solution, which is stored at -20°C away from light.

[0079] Specifically, refer to Figure 1 , a physical picture of the hydrogel's gelation is given. It can be seen that the hydrogel has good gelation properties and appears light milky white due to the loading of EACP.

[0080] Figure 2 The scanning electron microscopy image of the hydrogel is given, showing that CAT-GelMa / EACP has good porosity and appropriate pore size, which is conducive to the 3D culture of cells.

[0081] Figure 3 The rheological curve of the hydrogel is given, indicating that CAT-GelMa / EACP has good mechanical properties, the storage modulus is greater than the loss modulus, and it is consistent with the characteristics of elastic solids. Compared with CAT-GelMa / DNA / EACP in Example 1, the elastic modulus is reduced, which is mainly due to the lack of the physical cross-linking network formed by non-covalent binding of DNA molecules.

[0082] Figure 4The CCK-8 results of the hydrogel's effect on cell proliferation in 2D culture are given. Similar to the control group, there was no significant difference in the proliferation of BMSCs in the CAT-GelMa / EACP group, indicating that the hydrogel has good biocompatibility.

[0083] Figure 4 The alkaline phosphatase staining diagram of the hydrogel promoting the osteogenic differentiation of bone marrow mesenchymal stem cells is given. Compared with the control group, the alkaline phosphatase content of the cells in the CAT-GelMa / EACP group is higher, indicating that the hydrogel has a promoting effect on osteogenic differentiation. Compared with the CAT-GelMa / DNA / EACP of Example 1, the content of alkaline phosphatase is reduced, which is mainly due to the lack of the osteogenic effect of DNA molecules.

[0084] Figure 6 The alizarin red staining diagram of the hydrogel promoting the osteogenic differentiation of bone marrow mesenchymal stem cells is given. Compared with the control group, the content of calcium nodules generated by cells in the CAT-GelMa / EACP group is higher, indicating that the hydrogel can effectively promote the osteogenic mineralization of cells. Compared with the CAT-GelMa / DNA / EACP of Example 1, the content of calcium nodules is reduced, which is mainly due to the lack of DNA molecules as a biomimetic mineralization template, and the period required for mineralization is prolonged.

[0085] Figure 7 The fluorescence staining and quantitative graphs of the hydrogel reducing the production of intracellular reactive oxygen species in bone marrow mesenchymal stem cells after LPS stimulation are given. Compared with the control group, there was no significant difference in the content of reactive oxygen species in the CAT-GelMa / EACP group. Compared with the CAT-GelMa / DNA / EACP of Example 1, the content of reactive oxygen species increased, which was mainly due to the fact that EACP stimulated the production of intracellular reactive oxygen species, which partially offset the scavenging effect of CAT on reactive oxygen species.

[0086] Figure 8 The fluorescence staining results of the hydrogel promoting angiogenesis of human umbilical vein endothelial cells are shown. Compared with the control group, the number of tubes and branches in the CAT-GelMa / EACP group is greater, indicating that the hydrogel can effectively promote blood vessel formation. Compared with the CAT-GelMa / DNA / EACP of Example 1, the formation of blood vessels is reduced.

[0087] Embodiment 3:

[0088] Preparation of CAT-GelMa

[0089] This embodiment provides a method for preparing a matrix material for culturing woven organoids. Based on GelMa, catalase (CAT) is introduced to prepare an immobilized enzyme hydrogel (CG). Compared with Example 1, the difference of this embodiment is:

[0090] In S1-S5, the synthesis of the energy-active calcium phosphate described in S4 and the preparation of the DNA solution described in S5 are omitted.

[0091] S1: provides antioxidant enzymes; AC-PEG-NHS chemical crosslinker, LAP photoinitiator;

[0092] S2: Mix the antioxidant enzyme solution and 0.5% LAP aqueous solution, add AC-PEG-NHS, vortex and shake for 5 minutes in the dark, filter and sterilize with a 0.22 μm filter membrane, and incubate at 4°C in the dark for 18 to 24 hours;

[0093] S3: Prepare GelMa solution, soak GelMa in PBS, heat and dissolve at 60-70°C for 20-120 minutes, filter and sterilize with a 0.22 μm filter membrane to prepare GelMa solution, and store at a temperature below -20°C;

[0094] S4: omitted, none;

[0095] S5: omitted, none;

[0096] S6: Mix the solution obtained in S2 with the solution obtained in S3 in a mass ratio of 1:1, vortex mix thoroughly to prepare a hydrogel precursor solution, and store it at -20°C away from light.

[0097] Specifically, refer to Figure 1 , a physical picture of the hydrogel's gelation is given. It can be seen that the hydrogel has good gelation properties and appears transparent and light yellow due to the grafting of CAT.

[0098] Figure 2 The scanning electron microscopy image of the hydrogel is given, showing that CAT-GelMa has good porosity and appropriate pore size, which is conducive to the 3D culture of cells.

[0099] Figure 3 The rheological curve of the hydrogel is given, indicating that CAT-GelMa has good mechanical properties, the storage modulus is greater than the loss modulus, which is consistent with the characteristics of elastic solids. Compared with CAT-GelMa / EACP in Example 2, the elastic modulus is reduced, which is mainly due to the lack of support from EACP minerals.

[0100] Figure 4 The CCK-8 results of the hydrogel's effect on cell proliferation in 2D culture are given. Similar to the control group, there was no significant difference in the proliferation of BMSCs in the CAT-GelMa group, indicating that the hydrogel has good biocompatibility.

[0101] Figure 5The alkaline phosphatase staining diagram of the hydrogel promoting the osteogenic differentiation of bone marrow mesenchymal stem cells is given. Compared with the control group, the alkaline phosphatase content of the cells in the CAT-GelMa group is higher, indicating that the hydrogel has a promoting effect on osteogenic differentiation. Compared with the CAT-GelMa / EACP of Example 2, the alkaline phosphatase content is reduced, which is mainly due to the lack of EACP to provide mineral ions, slowing down the cell osteogenic process.

[0102] Figure 6 The alizarin red staining image of the hydrogel promoting calcium nodules of bone marrow mesenchymal stem cells is given. Compared with the control group, the content of calcium nodules generated by cells in the CAT-GelMa group is higher, indicating that the hydrogel can effectively promote the osteogenic mineralization of cells. Compared with the CAT-GelMa / EACP of Example 2, the formation of calcium nodules is reduced, which is mainly due to the lack of EACP to provide mineral ions, slowing down the cell mineralization process.

[0103] Figure 7 The fluorescence staining and quantitative graphs of the hydrogel reducing the production of reactive oxygen species in bone marrow mesenchymal stem cells after LPS stimulation are given. Compared with the control group, the content of reactive oxygen species in the CAT-GelMa group was reduced.

[0104] Figure 8 The fluorescence staining results of the hydrogel promoting angiogenesis of human umbilical vein endothelial cells are shown. Compared with the control group, the number of tubes and branches in the CAT-GelMa group is greater, indicating that the hydrogel can effectively promote angiogenesis.

[0105] Example 4: Preparation of GelMa

[0106] Preparation of GelMa hydrogel (GM). Compared with Example 1, the differences of this example are:

[0107] S1: supply LAP photoinitiator;

[0108] S2: Prepare 0.5% LAP aqueous solution, filter it with a 0.22 μm filter membrane to sterilize it, and store it at 4°C away from light.

[0109] S3: Prepare GelMa solution, soak GelMa in PBS, heat and dissolve at 60-70°C for 20-120 minutes, filter and sterilize with a 0.22 μm filter membrane to prepare a 5-20% GelMa solution, and store at -20°C.

[0110] The synthesis of energy-active calcium phosphate and the preparation of DNA solution described in S4-S5 can be omitted.

[0111] S6: Mix the solution obtained in S2 with the solution obtained in S3 in a mass ratio of 1:1, vortex mix thoroughly to prepare a hydrogel precursor solution, and store it at -20°C away from light.

[0112] Specifically, refer to Figure 1 , a physical picture of the hydrogel's gelation is given. It can be seen that the hydrogel has good gelation properties and is transparent.

[0113] Figure 2 The scanning electron micrograph of the hydrogel is given, showing that GelMa has good porosity and suitable pore size, which is conducive to the 3D culture of cells.

[0114] Figure 3 The rheological curve of the hydrogel is given, indicating that GelMa has good mechanical properties, the storage modulus is greater than the loss modulus, and it is consistent with the characteristics of elastic solids.

[0115] Figure 4 The CCK-8 results of the hydrogel's effect on cell proliferation in 2D culture are given. Similar to the control group, there was no significant difference in the proliferation of BMSCs in the GelMa group, indicating that the hydrogel has good biocompatibility.

[0116] Figure 5 The alkaline phosphatase staining diagram of the hydrogel's effect on promoting osteogenic differentiation of bone marrow mesenchymal stem cells is given. Compared with the control group, the alkaline phosphatase content in the GelMa group was slightly increased.

[0117] Figure 6 The Alizarin red staining image of the hydrogel promoting the formation of calcium nodules in bone marrow mesenchymal stem cells is given. Compared with the control group, the content of calcium nodules in the GelMa group was slightly increased.

[0118] Figure 7 The fluorescence staining and quantitative graphs of the hydrogel reducing the production of reactive oxygen species in bone marrow mesenchymal stem cells after LPS stimulation are given. Compared with the control group, there was no significant difference in the content of reactive oxygen species in the GelMa group.

[0119] Figure 8 The fluorescence staining results of the hydrogel promoting angiogenesis of human umbilical vein endothelial cells are shown. Compared with the control group, there was no significant difference in the effect of vascular network formation in the GelMa group.

[0120] Example 5

[0121] This embodiment provides a matrix material for culturing woven organoids, which is manufactured using the preparation method involved in the technical solution described in any one of the above embodiments 1 to 4.

[0122] Embodiment 6:

[0123] This example is the application of the matrix material described in Example 5 in woven bone organoid culture.

[0124] (1) 3D culture of woven bone organoids. BMSCs were expanded in large quantities, and the cells were collected by trypsin digestion, centrifuged, and the supernatant was discarded. The cells were resuspended in a 37°C hydrogel precursor solution, and directly injected into the well plate under warm conditions. They were irradiated under a 405nm light source for 10-60s to gel. The culture medium was added to the wells to cover the gel, placed in a 37°C incubator for 5 minutes, and then replaced with MEM complete culture medium for 1-3 days.

[0125] (2) Osteogenic induction of woven bone organoids. The 3D constructs were prepared with osteoinduction medium (DMEM basal medium, 10% FBS, 1% PS, 10 nM β-GP, 50 μg / mL Vitamin C, 10 nM Dex) and cultured in MEM complete medium for 1-3 days for adaptive proliferation. After 21 days of culture, woven bone organoids were formed for subsequent analysis.

[0126] Specifically, Fig. 9 This is a macroscopic picture of the matrix material used in the present invention to construct woven bone organoids and the cell morphology under bright field; it can be seen that the woven bone organoids cultured using CGDE hydrogel as the matrix material are whiter in color than tissues of other materials, indicating the large-scale production of minerals in the organoids. In addition, under the microscopic view, the cells aggregate into balls and extend pseudopodia, indicating that the cells in the tissue are more active.

[0127] Fig.10 The three-dimensional live-dead staining and three-dimensional skeleton staining of cells in woven bone organoids using the matrix material of the present invention. It can be seen that the cells in the woven bone organoids cultured using the CGDE matrix material are more active and the cytoskeleton is more spread, which further illustrates that the CGDE matrix material provides a good physicochemical microenvironment for organoid growth, which is conducive to the proliferation and migration of cells in the material.

[0128] Fig.11 The following are the Micro-CT three-dimensional reconstruction images after the matrix material of the present invention is used to construct woven bone organoids and the scanning images of the sagittal and horizontal planes of the woven bone organoids. It can be seen that a large amount of minerals are produced in the woven bone organoids cultured using the CGDE matrix material, and they have the ability of autonomous mineralization.

[0129] The above is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any technician familiar with the technical field can easily think of various equivalent modifications or replacements within the technical scope disclosed in the present application, and these modifications or replacements should be included in the protection scope of the present application. Therefore, the protection scope of the present application shall be based on the protection scope of the claims.

Claims

1. A method for preparing a matrix material for culturing woven organoids, characterized in that: The following steps are involved: S1: Provides antioxidant enzymes; AC-PEG-NHS chemical crosslinker, LAP photoinitiator; S2: Mix the antioxidant enzyme solution and 0.5% LAP aqueous solution, add AC-PEG-NHS, vortex and shake for 5 minutes in the dark, filter and sterilize with a 0.22 μm filter membrane, and incubate at 4 ° C in the dark for 18 to 24 hours; S3: Prepare GelMa solution, soak GelMa in PBS, heat and dissolve at 60-70°C for 20-120 minutes, filter and sterilize with a 0.22 μm filter membrane to prepare GelMa solution, and store at a temperature below -20°C; S4: Synthesize energy-active calcium phosphate or provide other calcium phosphate or mineral materials; S5: Prepare DNA solution, add DEPC water to Y-1, Y-2, Y-3, L-1, and L-2, vortex to dissolve, mix Y-1, Y-2, and Y-3 to prepare a Y-DNA mixed solution, mix L-1 and L-2 to prepare an L-DNA mixed solution, and store at a temperature below -20°C; S6: the solution obtained in S2 is mixed with the solution obtained in S3 at a mass ratio of 1:1, and the energy-active calcium phosphate obtained in S4, the Y-DNA solution obtained in S5 and the L-DNA solution are added, and the mixture is vortexed thoroughly to prepare a hydrogel precursor solution, which is stored at a temperature below -20°C away from light; S7: The hydrogel precursor solution obtained in S6 is irradiated under a 405 nm light source for 10-60 s to gelate it for two-dimensional cell culture; for organoid culture, the cells are resuspended with the hydrogel precursor solution obtained in S6 and then gelated.

2. A method for preparing a matrix material for culturing woven organoids according to claim 1, characterized in that: The concentration of the antioxidant enzyme solution in S2 is 10-200 mg / mL; the molar ratio of AC-PEG-NHS to antioxidant enzyme in the solution obtained in S2 is 2:1 to 6:1, and the AC-PEG-NHS can also be replaced by other chemical cross-linking agents such as EDC and NHS.

3. The method for preparing a matrix material for culturing woven organoids according to claim 1, characterized in that: The amino substitution degree of the GelMa obtained in S3 is 10% to 90%, and the concentration of the solution is 1% to 20%.

4. The method for preparing a matrix material for culturing woven organoids according to claim 1, characterized in that: S4 The synthesis of energy-active calcium phosphate is carried out by breaking high-energy phosphate bonds of high-energy phosphate molecules under enzyme catalysis to provide phosphate ions and energy, and the phosphate ions combine with calcium ions in the solution to generate energy-active calcium phosphate. The specific steps are: S41: Provide adenosine triphosphate, creatine phosphate or other high-energy phosphate molecules, calcium chloride or other water-soluble calcium salts and alkaline phosphatase. S42: Add 1.5 mL of an aqueous solution containing 10 to 650 mg of high-energy phosphoric acid molecules and 1 mL of an aqueous solution containing 5 to 100 mg of a water-soluble calcium salt to 60 mL of water. S43: The pH of the solution obtained in S42 is adjusted to 8.0-8.5 with 0.2 M NaOH solution. S44: Add 0.1 mL of an aqueous solution containing 1 to 20 mg of alkaline phosphatase to the solution obtained in S43 and react for 0.5 to 12 hours under magnetic stirring at room temperature. During the reaction, the pH is maintained at 8.0 to 8.

5. S45: Centrifuge the reaction solution obtained in S44 to obtain energy-active calcium phosphate, wash it with ultrapure water and anhydrous ethanol at least once each, and store it in anhydrous ethanol at -20°C.

5. The method for preparing a matrix material for culturing woven organoids according to claim 1, characterized in that: The molar concentration of the Y-DNA and L-DNA solutions described in S5 is 5 to 200 μM.

6. The method for preparing a matrix material for culturing woven organoids according to claim 1, characterized in that: The mass concentration of energy-active calcium phosphate in the hydrogel precursor solution obtained in S6 is 1-200 mg / mL; the molar concentration of Y-DNA and L-DNA in the hydrogel precursor solution obtained in S6 is 10-2000 nM.

7. The method for preparing a matrix material for culturing woven organoids according to claim 1, characterized in that: The two-dimensional cell culture method described in S7 is as follows: melt the hydrogel precursor in a 37°C water bath away from light, inject it into the well plate in a warm state, and irradiate it under a 405nm light source for 10-60s to gel it. Add the culture medium into the well to cover the gel, place it in a 37°C incubator for 5 minutes, and then switch to the cell suspension for culture.

8. A matrix material for culturing woven bone organoids, characterized in that: The matrix material is prepared by the method for preparing the matrix material for culturing woven bone organoids according to any one of claims 1 to 9.

9. Use of the preparation method according to any one of claims 1 to 7 or the matrix material for culturing woven bone organoids according to claim 8 in the preparation of bone repair and bone regeneration materials.

10. Use of a matrix material for culturing woven bone organoids in the preparation of bone repair and bone regeneration materials, the use according to claim 9, characterized in that: The application is to use the double-network composite hydrogel material as an organoid culture matrix to form woven bone organoids after inducing differentiation.

Citation Information

Cited By

  • Bone organ for promoting nerve ingrowth and construction method and application thereof

    CN120866213A

  • Conductive polymer-induced collagen hydrogel mineralized scaffold, preparation method thereof and application of conductive polymer-induced collagen hydrogel mineralized scaffold in construction of bone organs

    CN120988992A

  • Method for evaluating intestinal flora extracellular vesicles regulating bone metabolism based on intestine-bone axis multi-organ chip

    CN122727348A